We are pleased to join this collaborative effort to develop and assess the safety, 免疫原性, and effectiveness of an adenovirus type 4 based vaccine expressing the SARS-CoV-2 spike protein as a novel approach to the prevention of 新型冠状病毒肺炎。.
Peter F. 莱特博士与 National Institutes of 健康 (NIH) and Belgium-based viral vector manufacturer Exothera, a team of researchers at 十大博彩推荐排名卫生’s Dartmouth Hitchcock Medical Center (DHMC) and Dartmouth’s 盖泽尔医学院 are working to develop the first intranasal 新型冠状病毒肺炎。 vaccine brought to market. Led by DHMC infectious disease and international health physician Peter F. 莱特博士, this nasal-spray vaccine will not require refrigeration and does not need to be administered by a medical professional, making it a critical tool in the fight against 新型冠状病毒肺炎。 in developing parts of the world.
DHMC是美国唯一的.S. research and development site for this novel vaccine. Clinical trials are planned in the U.S. 和非洲. Intranasal vaccines show great potential to slow the transmission of 新型冠状病毒肺炎。 as they have been used successfully in the past against other pathogens that enter the body via mucous membranes, 包括麻疹, rubella and other respiratory viruses.
“We are pleased to join this collaborative effort to develop and assess the safety, 免疫原性, and effectiveness of an adenovirus type 4 based vaccine expressing the SARS-CoV-2 spike protein as a novel approach to the prevention of 新型冠状病毒肺炎。,赖特说。, who is also a professor of pediatrics at Geisel. “Although unique in the COVID field, the vaccine has precedent in the highly successful prevention of adenovirus respiratory disease in the United States military.”
Despite the rapid development of injectable 新型冠状病毒肺炎。 vaccines, a majority of low-income and lower-middle-income countries were unable to achieve proper population coverage during initial vaccine rollouts. 即使是现在, the percentage of the population fully vaccinated is below the level necessary to prevent continued transmission. A vaccine that can be administered by anyone via nasal spray is anticipated to be highly effective in interrupting the transmission of 新型冠状病毒肺炎。, as has been done successfully with oral drops given globally to prevent polio.
Clips from the video below are cleared for use by news media outlets on all digital and broadcast platforms, with credit to 十大博彩推荐排名卫生.
关于十大博彩推荐排名健康学院
十大博彩推荐排名卫生, New Hampshire's only academic health system and the state's largest private employer, serves patients across northern New England. 十大博彩推荐排名卫生 provides access to more than 2,000 providers in almost every area of medicine, delivering care at its flagship hospital, Dartmouth Hitchcock Medical Center (DHMC) in Lebanon, NH, as well as across its wide network of hospitals, 诊所及护理设施. DHMC is consistently named the #1 hospital in New Hampshire by U.S. 新闻 & 世界报道, and recognized for high performance in numerous clinical specialties and procedures. 十大博彩推荐排名健康中心包括 十大博彩推荐排名癌症中心, one of only 56 National Cancer Institute-designated Comprehensive Cancer Centers in the nation, and the only such center in northern New England; 十大博彩推荐排名健康儿童医院, which includes Children’s Hospital at Dartmouth Hitchcock Medical Center, the state’s only children’s hospital, and multiple clinic locations around the region; member hospitals in Lebanon, 基恩和新伦敦, NH, 本宁顿和温莎, VT; Visiting Nurse and Hospice for Vermont and New Hampshire; and more than 24 clinics that provide ambulatory services across New Hampshire and Vermont. Through its historical partnership with Dartmouth and the 盖泽尔医学院, 十大博彩推荐排名卫生 trains nearly 400 medical residents and fellows annually, and performs cutting-edge research and clinical trials recognized across the globe with Geisel and the White River Junction VA Medical Center 在佛蒙特州的白河枢纽. 十大博彩推荐排名卫生 and its more than 13,000 employees are deeply committed to serving the healthcare needs of everyone in our communities, and to providing each of our patients with exceptional, 个人护理.